SCHEMBL13781015

SCHEMBL13781015

Cc1ccc(N(c2ccc(C)cc2)c2cccc(C(=O)c3cccc(N(c4cccc(C(=O)c5cccc(N(c6ccc(C)cc6)c6ccc(C)cc6)c5)c4)c4cccc(C(=O)c5cccc(N(c6ccc(C)cc6)c6ccc(C)cc6)c5)c4)c3)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ HPGD P15428 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SRD5A2 P31213 1/20 0.41
▸ CES2 O00748 1/20 0.41
▸ CES1 P23141 1/20 0.41
▸ CNR2 P34972 1/20 0.41
▸ HTT P42858 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ POLB P06746 2/20 0.40
▸ HSD17B1 P14061 1/20 0.40
▸ HSD17B2 P37059 1/20 0.40
▸ MITF O75030 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13780980 0.98 TDP1 (0.47) LMNAALDH1A1TDP1ATML3MBTL1
SCHEMBL13780986 0.95 L3MBTL1 (0.53) LMNAALDH1A1TDP1ATML3MBTL1
SCHEMBL28654162 0.87 POLB (0.49) TDP1ATML3MBTL1HPGDCNR2
SCHEMBL27828940 0.85 L3MBTL1 (0.61) LMNAALDH1A1TDP1ATML3MBTL1
SCHEMBL22175357 0.84 ALDH1A1 (0.45) LMNAALDH1A1TDP1ATML3MBTL1
SCHEMBL12551413 0.84 ALDH1A1 (0.45) LMNAALDH1A1TDP1ATML3MBTL1
SCHEMBL13780988 0.84 ATM (0.38) LMNAALDH1A1TDP1ATML3MBTL1
SCHEMBL13781089 0.83 L3MBTL1 (0.65) LMNAALDH1A1TDP1ATML3MBTL1
SCHEMBL134215 0.83 ALDH1A1 (0.52) LMNAALDH1A1TDP1ATMHPGD
SCHEMBL12374369 0.82 ALDH1A1 (0.52) LMNAALDH1A1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2024465-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-01-13 — — EP disclosed
US-9206351-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-12-08 — — US disclosed
US-9206351-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-12-08 — — US disclosed
US-20090167166-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2009-07-02 — — US disclosed
US-20090167166-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090167166-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES PIEZO1, OR10J3, PUF60 LMNA 1144/4885ALDH1A1 504/4885TDP1 1282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback